Working... Menu

Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions (PRECISION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01917682
Recruitment Status : Completed
First Posted : August 7, 2013
Last Update Posted : June 12, 2017
Information provided by (Responsible Party):
Corindus Inc.

Brief Summary:
To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI procedures.

Condition or disease Intervention/treatment
Coronary Artery Disease Coronary Disease Myocardial Ischemia Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Procedure: CorPath-assisted Percutaneous Coronary Intervention

Detailed Description:
This is a prospective, single-arm, open-label, multi-center patient registry of the CorPath 200 System to examine its performance during PCI procedure and patient outcomes through 72 hours post-procedure or hospital discharge, whichever occurs first.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 754 participants
Observational Model: Cohort
Time Perspective: Other
Target Follow-Up Duration: 3 Days
Official Title: A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions
Actual Study Start Date : August 2013
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Group/Cohort Intervention/treatment
Study Cohort
Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)
Procedure: CorPath-assisted Percutaneous Coronary Intervention
Robotic-assisted Percutaneous Coronary Intervention
Other Name: Robotic-assisted Percutaneous Coronary Intervention

Primary Outcome Measures :
  1. Clinical Success [ Time Frame: In-hospital (72 hours or discharge, whichever occurs first) ]
    Less than 30% residual stenosis post PCI in the lesion(s) treated with the CorPath system, without in-hospital major adverse coronary events (MACE).

Secondary Outcome Measures :
  1. In-hospital Major Adverse Coronary Events (MACE) [ Time Frame: In-hospital (72 hours or discharge, whichever occurs first) ]
    The composite of death, myocardial infarction, and target vessel revascularization that occurs within 72 hours of the procedure or prior to hospital discharge, whichever occurs first, in a subject treated with the CorPath 200 System.

  2. Adverse Events [ Time Frame: In-hospital (72 hours or discharge, whichever occurs first) ]
    All Serious Adverse Events (SAEs) and Unanticipated Adverse Device Effects (UADEs) from the start of the CorPath procedure until the end of the study will be summarized.

Other Outcome Measures:
  1. Overall Procedure Time [ Time Frame: During procedure ]
    Defined as the time measured from the insertion of the hemostasis sheath until the removal of the guide catheter.

  2. PCI Procedure Time [ Time Frame: During procedure ]
    Defined as the time measured from the insertion of the guide catheter until the removal of the guide catheter.

  3. Fluoroscopy and/or X-Ray Time [ Time Frame: During procedure ]
    As recorded by an X-Ray System utilized during the procedure.

  4. Patient Radiation Exposure [ Time Frame: During procedure ]
    DAP (dose-area-product) and cumulative dose as recorded during the procedure.

  5. Contrast Fluid Volume [ Time Frame: During procedure ]
    No additional description

  6. Number of Conversions to Manual [ Time Frame: During procedure ]
    The overall number of conversions from the robotic PCI to manual PCI will be captured to analyze the technical success of the device.

  7. Measurement of Lesion and Stented Segment Length [ Time Frame: During procedure ]
    1. Visual estimate by clinical operator prior to delivery of PCI device(s).
    2. CorPath 200 System measurement of the segment planned for treatment and length of deployed stent.
    3. Quantitative Coronary Angiography (QCA) of stented segment length

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects with coronary artery disease and with the clinical indication for Percutaneous Coronary Intervention (PCI).

Inclusion Criteria:

  1. Age >18 years.
  2. Patients with coronary artery disease undergoing Percutaneous Coronary Intervention (PCI) with the CorPath 200 system.
  3. The subject or the legal representative has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.

Exclusion Criteria:

  1. Concurrent enrollment in another device or drug study protocol that specifically excludes concurrent enrollment or that prevents collection of data required in this registry (concurrent participation in another registry is not an automatic exclusion criterion for this study).
  2. Failure/inability/unwillingness to provide informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01917682

Layout table for location information
United States, California
UC San Diego Medical Center
San Diego, California, United States, 92103
United States, Colorado
Valley View Hospital
Glenwood Springs, Colorado, United States, 81601
United States, District of Columbia
Medstar Washington Hospital Center
Washington, D.C., District of Columbia, United States, 20010
United States, Florida
Orlando Regional Medical Center
Orlando, Florida, United States, 32806
United States, Georgia
North Georgia Heart Foundation
Gainesville, Georgia, United States, 30501
United States, Massachusetts
St. Elizabeth's Medical Center
Boston, Massachusetts, United States, 02135
United States, Michigan
Spectrum Health System
Grand Rapids, Michigan, United States, 49503
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55906
United States, New York
Columbia University Medical Center/New York-Presbyterian Hospital
New York, New York, United States, 10032
St. Joseph's Hospital Health Center
Syracuse, New York, United States, 13203
United States, North Carolina
Carolinas Medical Center - Northeast
Concord, North Carolina, United States, 28203
United States, Ohio
University Hospitals Case Medical Center
Cleveland, Ohio, United States, 44106
United States, South Dakota
Sanford Health
Sioux Falls, South Dakota, United States, 57104
United States, Virginia
University of Virginia
Charlottesville, Virginia, United States, 22908
Virginia Commonwealth Univ. Medical Center
Richmond, Virginia, United States, 23298
Shaare Zedek Medical Center
Jerusalem, Israel, 91031
Sponsors and Collaborators
Corindus Inc.
Layout table for investigator information
Principal Investigator: Giora Weisz, MD Columbia University Medical Center/New York-Presbyterian Hospital
Study Director: Chris Cain VP, Clinical Affairs

Additional Information:
Layout table for additonal information
Responsible Party: Corindus Inc. Identifier: NCT01917682     History of Changes
Other Study ID Numbers: PRECISION CorPath Registry
First Posted: August 7, 2013    Key Record Dates
Last Update Posted: June 12, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Corindus Inc.:
robotic-assisted PCI
coronary intervention
CorPath PRECISION Registry

Additional relevant MeSH terms:
Layout table for MeSH terms
Cardiovascular Diseases
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Vascular Diseases
Arterial Occlusive Diseases
Pathologic Processes